/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/5000x1496/8aa45c8224/eacvi-acronym-text-rgb.png)
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Non-classical risk factors for heart disease revisited
Event: ESC Congress 2024
Topic: Risk Factors and Prevention
Session type: Abstract Sessions
Cardio-oncology in practice
Event: ESC Congress 2024
Topic: Cardio-Oncology
Session type: Abstract Sessions
T-cells, checkpoint inhibitors, and cardiac complications
Event: ESC Congress 2023
Topic: Cardio-Oncology
Session type: Moderated ePosters
Great Debate: controversies in the contemporary management of HFrEF
Event: ESC Congress 2023
Topic: Cardiovascular Pharmacotherapy
Session type: Great Debates
Cardiovascular risk in patients with cancer
Event: ESC Congress 2023
Topic: Cardio-Oncology
Session type: Moderated ePosters
Cardio-oncology: the new kid on the block for multi-modality imagers
Event: EACVI 2023
Topic: Imaging of Myocardial Disease
Session type: Symposium
Heart Failure 1
Event: EACVI 2023
Topic: Cross-Modality and Multi-Modality Imaging Topics
Session type: Moderated ePosters
Cardio-oncology 3
Event: ESC Congress 2022
Topic: Cardio-Oncology
Session type: Moderated ePosters
When is the time to implement novel biomarkers routinely?
Event: ESC Congress 2022
Topic: Biomarkers
Session type: Advances in Science
Keeping calm and use of stress echocardiography in valve disease
Event: EuroEcho 2021
Topic: Valvular Heart Disease
Session type: Symposium
